human
coronaviru
identifi
subsequ
studi
show
worldwid
distribut
infect
pathogen
associ
upper
lower
respiratori
tract
diseas
mild
moder
sever
furthermor
main
caus
croup
children
within
studi
optim
protocol
freezedri
allow
safe
effect
preserv
infecti
materi
develop
lyophil
viru
prepar
store
either
ambient
temperatur
c
latter
case
sampl
may
store
least
two
month
surprisingli
conduct
analysi
show
virion
exquisit
stabl
liquid
media
store
also
without
preserv
ambient
temperatur
day
east
respiratori
syndrom
coronaviru
merscov
cross
speci
border
prove
emerg
sarscov
isol
case
center
diseas
prevent
zaki
et
al
intensifi
research
coronavirus
develop
novel
research
tool
base
coronavir
backbon
eg
vector
vaccin
requir
method
safe
storag
shipment
infecti
materi
coronaviru
particl
rel
stabl
previou
report
show
stabil
insuffici
storag
transport
coronavirusbas
vaccin
vector
materi
exchang
laboratori
lamarr
talbot
muller
et
al
lyophil
method
choic
costeffect
stabil
infecti
materi
process
sampl
frozen
subsequ
solvent
remov
sublim
primari
dri
desorpt
secondari
dri
level
inhibit
biolog
growth
chemic
reaction
jen
improv
stabil
sampl
lyophil
storag
stabil
substanc
includ
lyoprotect
townsend
deluca
bulk
agent
jen
ad
numer
report
describ
freezedri
virus
mainli
vaccin
product
amorij
et
al
audouy
et
al
bieganski
et
al
burger
et
al
croyl
et
al
de
jong
et
al
furuya
et
al
geeraedt
et
al
gupta
et
al
kang
et
al
lang
et
al
levi
fieldsteel
yannarel
et
al
method
differ
term
process
paramet
buffer
content
stabil
prepar
rang
week
http
elsevi
bv
right
reserv
c
de
jong
et
al
one
year
ambient
temperatur
geeraedt
et
al
levi
fieldsteel
precausta
et
al
develop
protocol
allow
storag
infecti
bronchiti
viru
ibv
month
c
use
mgml
mannitol
lyoprotect
precausta
et
al
roseto
et
al
lyophil
bovin
enter
coronaviru
without
addit
stabil
formul
structur
studi
use
electron
microscopi
roseto
et
al
viru
stabil
storag
test
studi
freezedri
preserv
coronavirus
includ
human
coronavirus
previous
report
human
coronaviru
belong
genu
alphacoronaviru
intern
committe
taxonomi
virus
king
pyrc
et
al
pyrc
et
al
van
der
hoek
et
al
pathogen
spread
worldwid
respons
case
viral
respiratori
tract
diseas
bastien
et
al
cabeca
et
al
gaunt
et
al
kon
et
al
moe
et
al
symptom
upper
respiratori
tract
infect
includ
rhiniti
cough
fever
sore
throat
infect
lower
respiratori
tract
manifest
bronchiti
bronchiol
pneumonia
pyrc
et
al
furthermor
prove
main
caus
croup
children
sung
et
al
van
der
hoek
et
al
aim
studi
develop
safe
method
freezedri
preserv
infecti
end
cell
atcc
macaca
mulatta
kidney
epitheli
cell
line
use
vitro
cultur
schildgen
et
al
cell
cultur
flask
tpp
germani
c
co
minim
essenti
medium
mem
contain
part
hank
mem
part
earl
mem
life
technolog
poland
supplement
heatinactiv
fetal
bovin
serum
life
technolog
poland
penicillin
uml
streptomycin
gml
medium
amsterdam
strain
stock
gener
infect
cell
infect
cell
lyse
day
postinfect
two
freezethaw
cycl
viruscontain
fluid
clear
centrifug
aliquot
store
c
control
mock
infect
cell
prepar
manner
viru
stock
viru
yield
assess
viru
titrat
fulli
confluent
cell
accord
reed
muench
formula
reed
muench
formul
use
lyophil
present
tabl
prepar
concentr
solut
distil
water
five
time
concentr
hb
buffer
prepar
distil
water
sampl
steril
filtrat
sampl
prepar
follow
formul
l
hb
l
steril
water
l
concentr
stabil
formul
l
stock
tcid
million
medium
ps
formul
l
steril
water
l
concentr
stabil
formul
l
stock
tcid
million
medium
ps
hb
control
l
hb
l
steril
water
l
stock
tcid
million
medium
ps
pb
control
l
pb
nacl
gl
kcl
gl
na
hpo
gl
kh
po
gl
ph
l
stock
tcid
million
medium
ps
ps
solut
prepar
ml
tube
sarstdedt
germani
snap
frozen
liquid
nitrogen
posit
within
steril
precool
lyophil
contain
open
cap
dri
process
carri
shelf
lyophil
tmfreezon
triad
labconco
attach
vacuum
pump
labconco
ensur
safeti
seal
box
prepar
poli
methyl
methacryl
rubber
seal
contain
design
standard
probe
stand
steril
box
disinfect
ethanol
expos
ultraviolet
radiat
ga
exchang
contain
lyophil
possibl
via
vent
protect
air
filter
sartoriu
stedim
germani
lyophil
contain
precool
c
process
paramet
chosen
base
literatur
data
order
maintain
stabl
temperatur
apparatu
stabil
h
process
shelf
temperatur
c
collector
temperatur
c
vacuum
first
dri
step
carri
h
c
pressur
mbar
time
temperatur
increas
c
process
carri
anoth
h
subsequ
sampl
contain
transfer
laminar
flow
hood
cap
sampl
store
c
c
room
temperatur
stabil
test
freezedri
viru
dissolv
l
steril
water
incub
c
mix
min
facilit
dissolv
cake
obtain
solut
dilut
time
medium
cell
seed
cultur
plate
incub
h
c
co
obtain
fulli
confluent
cell
monolay
medium
remov
cell
fresh
medium
contain
serial
dilut
viru
control
sampl
reconstitut
lyophil
materi
ad
two
hour
postinocul
medium
remov
fresh
medium
appli
six
day
post
infect
cytopath
effect
cell
assess
obtain
data
recalcul
tcid
accord
reed
muench
formula
reed
muench
primari
screen
differ
buffer
composit
reveal
alreadi
freezedri
process
formul
provid
suffici
protect
first
hb
buffer
select
pb
buffer
pb
exhibit
signific
ph
instabl
freez
process
amorij
et
al
second
requir
bulk
agent
confirm
line
myoinositol
gl
gl
leucin
myoinositol
gl
gl
gelatin
sampl
supplement
gelatin
gl
except
formul
larginin
gl
alanin
gl
histidin
gl
present
data
shown
relat
pb
control
formul
name
describ
tabl
observ
made
jen
lack
bulk
agent
eg
sampl
result
excess
foam
freezedri
process
render
storag
sampl
imposs
convers
sampl
buffer
contain
similar
concentr
sucros
sampl
buffer
produc
freezedri
cake
good
structur
properti
explain
presenc
gelatin
formul
contain
high
concentr
sugar
sorbitol
inulin
turn
toxic
cell
incub
viru
prevent
cytotox
effect
formul
virusmock
medium
appli
cell
h
follow
time
cell
wash
fresh
medium
appli
sampl
lyophil
tabl
buffer
show
lower
tcid
valu
compar
refer
sampl
ie
pb
hb
fig
conduct
experi
prove
mannitol
prefer
bulk
agent
compar
sorbitol
cell
toxic
observ
latter
carbohydr
former
one
analysi
show
also
myoinositol
optim
lyoprotect
virion
base
obtain
result
three
formul
yield
promis
result
select
select
sampl
contain
myoinositol
lyoprotect
mannitol
bulk
agent
buffer
supplement
gelatin
larginin
merck
germani
alanin
histidin
sigmaaldrich
poland
test
stabil
freezedri
viru
differ
condit
lyophil
sampl
store
c
c
room
temperatur
rt
prepar
lyophil
viru
solubil
day
postlyophil
titrat
set
origin
lyophil
sampl
store
ident
condit
lyophil
sampl
ps
medium
use
control
fig
conduct
analysi
reveal
two
formul
contain
myoinositol
gl
gl
gl
mannitol
supplement
gelatin
gl
larginin
gl
alanin
gl
histidin
gl
mm
hepe
provid
optim
stabil
virion
sampl
storag
c
c
day
affect
virion
infect
prepar
store
ambient
temperatur
consider
viru
titer
decreas
observ
first
week
like
result
hydrolysi
reaction
caus
residu
water
present
sampl
jen
measur
infect
lyophil
viru
assess
day
post
infect
assay
perform
duplic
least
three
independ
experi
averag
valu
standard
error
error
bar
present
time
point
repres
sampl
titrat
immedi
lyophil
formul
describ
tabl
graph
repres
sampl
store
c
c
b
ambient
temperatur
c
slight
increas
viru
titer
day
storag
c
storag
buffer
observ
similar
phenomenon
previous
observ
suggest
virion
aggreg
freezedri
process
lower
infect
prolong
storag
result
aggreg
dissoci
restor
infect
cowderi
et
al
coronaviru
stabil
suspens
research
sever
group
muller
et
al
show
still
infect
day
incub
ambient
temperatur
pb
medium
muller
et
al
suspens
infect
lost
day
incub
degre
lamarr
talbot
show
virion
still
detect
day
storag
cell
cultur
medium
room
temperatur
virion
retain
infect
c
day
show
similar
decreas
viru
tcid
freez
dri
sampl
summar
optim
protocol
freezedri
allow
safe
effect
preserv
infecti
materi
develop
safeti
process
provid
usag
inner
contain
seal
air
filtrat
unit
consid
need
distribut
known
novel
coronavir
pathogen
differ
laboratori
refer
materi
develop
method
may
facilit
shipment
process
significantli
lower
transport
cost
surprisingli
appear
virion
highli
stabl
store
ambient
temperatur
day
obtain
prepar
ship
either
ambient
temperatur
c
latter
case
sampl
may
store
least
two
month
